Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

2011164 citationsJournal Articlegold Open Access

Authors

Clinicaltrials.gov NCT00976118.

Good health and well-being

Published in: Alzheimer s Research & Therapy

Volume 3, Issue 2, pp. 16-16

Field-Weighted Citation Impact: 6.51